Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 274 clinical trials
None
EVOO Coratina Intervention on Lipids in Non-diabetic Hypertensive Patients Undergoing Hemodialysis (EVOOC-3H)

Twenty-four non-diabetic hypertensive and hyperlipidemic patients undergoing periodic chronic hemodialysis will be enrolled for receiving extravirgin olive oil (EVOO) Coratina (12 patients) or refined olive oil (12 patients). Aim of the study is to evaluate the effect of EVOO-C on serum lipid levels. Randomization will be done centrally with appropriate …

  • 0 views
  • 26 Jan, 2021
  • 1 location
None
The Effect of Sitagliptin on Hypertension Arterial Stiffness Oxidative Stress and Inflammation

Recently a new category of antihyperglycemic therapy aiming to modulate the incretin system has emerged. These drugs induce insulin secretion without inducing hypoglycemia. The effect of the incretin modulators drugs on hypertension, arterial stiffness, inflammation and oxidative stress parameters have not been fully investigated yet.GLP-1 analogue has been suggested to …

type 2 diabetes mellitus
arterial stiffness
dipeptidyl peptidase-4 inhibitor
sitagliptin
glycosylated hemoglobin
  • 11 views
  • 07 Nov, 2020
  • 1 location
None
Efficacy of PuraStat for the Prevention of Delayed Bleeding After Endoscopic Resection of Colorectal Lesions

A Prospective Interventional Multicentric Study to Evaluate Effectiveness and Safety of PuraStat in the Management of delayed bleeding following Endoscopic Mucosal Resection (EMR) in the colon and rectum.

  • 2 views
  • 24 Jan, 2021
  • 1 location
None
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease

This study will be a comparative effectiveness research to determine the difference in major adverse cardiovascular events between the group with aspirin after awakening and placebo before

  • 0 views
  • 23 Jan, 2021
  • 1 location
None
ASPIrin in Reducing Events in Dialysis ( ASPIRED )

deaths in patients with end stage kidney disease (ESKD). At the same time, this population has increased risks of clotting as well as bleeding episodes. While aspirin is known to reduce cardiovascular

  • 0 views
  • 25 Mar, 2021
  • 48 locations
None
Japanese Primary Prevention Project With Aspirin

The purpose of this study is to investigate the balance between the risks and benefits of primary prevention by Aspirin in elderly Japanese patients with one or more cerebro

hypercholesterolemia
hdl cholesterol
glycosylated hemoglobin
LDL Cholesterol
glucose tolerance test
  • 17 views
  • 07 Nov, 2020
  • 1 location
None
Adjuvant Low Dose Aspirin in Colorectal Cancer

ALASCCA is a randomized, parallel group, double blind, multicenter, placebo-controlled, biomarker-based study of adjuvant treatment with low dose aspirin in patients with colorectal cancer

rectal carcinoma
aspirin
  • 29 views
  • 14 Feb, 2021
  • 33 locations
None
Aspirin in Colorectal Cancer Liver Metastases

The ASAC trial is a Scandinavian, multi-center, double-blinded, randomized, placebo-controlled study to determine whether adjuvant treatment with low-dose acetylsalicylic acid (ASA) can improve disease free survival in patients treated with resection for colorectal cancer liver metastases (CRCLM). Several studies have shown beneficial effect of ASA on primary prevention of CRC …

liver metastasis
metastasis
aspirin
cancer
primary tumor
  • 205 views
  • 15 Jul, 2021
  • 20 locations
None
Rivaroxaban or Aspirin for Biological Aortic Prosthesis

recipient endothelium. There are no conclusive studies of anticoagulation and the investigators have shown stroke to be a common complication. Guidelines have variably recommended aspirin or rivaroxaban for

myocardial infarction
warfarin
blood clot
infarct
aortic valve replacement
  • 0 views
  • 22 Jan, 2021
  • 3 locations
None
Chronotherapy With Low-dose Aspirin for Primary Prevention

Brief summary: Aspirin (ASA) has been shown to provide marked benefits in primary and secondary prevention of cardiovascular events. Substantial evidence suggests that low-dose ASA

type 2 diabetes mellitus
fasting
hypertension
metabolic syndrome
aspirin
  • 21 views
  • 26 Jan, 2021
  • 22 locations